スポンサーリンク

Hematology and Cell Therapy Division, Aichi Cancer Center Hospital | 論文

• Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study

スポンサーリンク